123 related articles for article (PubMed ID: 2676648)
41. A double-blind randomized placebo controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the gastric mucosa of human volunteers.
Lanza FL; Umbenhauer ER; Nelson RS; Rack MF; Daurio CP; White LA
J Rheumatol; 1982; 9(3):415-9. PubMed ID: 6750118
[TBL] [Abstract][Full Text] [Related]
42. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
Larkai EN; Smith JL; Lidsky MD; Graham DY
Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
[TBL] [Abstract][Full Text] [Related]
43. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Imbesi V
Am J Gastroenterol; 1995 Sep; 90(9):1485-8. PubMed ID: 7661175
[TBL] [Abstract][Full Text] [Related]
44. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
45. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
Warrington S
Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
[TBL] [Abstract][Full Text] [Related]
46. Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study Group.
Bombardier C; Peloso PM; Goldsmith CH
J Rheumatol; 1995 Apr; 22(4):617-24. PubMed ID: 7791151
[TBL] [Abstract][Full Text] [Related]
47. [Gastroduodenal lesions in rheumatoid arthritis. Evaluation and treatment].
Martínez RO; Casas H; Mazure PA; Leczycki H; Cosen JN; Canievsky L; Abib A
Acta Gastroenterol Latinoam; 1988; 18(2):87-96. PubMed ID: 3075109
[TBL] [Abstract][Full Text] [Related]
48. A comparison of tenoxicam and piroxicam in the treatment of rheumatoid arthritis.
Atkinson M; Khanna V; Ménard H; Russel AS; Tannenbaum H
J Rheumatol; 1992 Apr; 19(4):538-42. PubMed ID: 1593574
[TBL] [Abstract][Full Text] [Related]
49. A double blind comparison of piroxicam and enteric coated ASA in rheumatoid arthritis. A Cooperative Multicenter Canadian trial.
J Rheumatol; 1985 Feb; 12(1):68-77. PubMed ID: 3884806
[TBL] [Abstract][Full Text] [Related]
50. Double-blind, parallel clinical trial of tenoxicam (Ro 12-0068) versus piroxicam in patients with ankylosing spondylitis.
Astorga G
Eur J Rheumatol Inflamm; 1987; 9(2):70-3. PubMed ID: 3329111
[No Abstract] [Full Text] [Related]
51. Salicylsalicylic acid causes less gastroduodenal mucosal damage than enteric-coated aspirin. An endoscopic comparison.
Scheiman JM; Behler EM; Berardi RR; Elta GH
Dig Dis Sci; 1989 Feb; 34(2):229-32. PubMed ID: 2914543
[TBL] [Abstract][Full Text] [Related]
52. Effects of D-002, a product isolated from beeswax, on gastric symptoms of patients with osteoarthritis treated with piroxicam: a pilot study.
Illnait J; Terry H; Más R; Fernández L; Carbajal D
J Med Food; 2005; 8(1):63-8. PubMed ID: 15857212
[TBL] [Abstract][Full Text] [Related]
53. [Kidney function in therapy with non-steroidal antiphlogistic drugs. A double-blind cross-over study with diclofenac, indomethacin and piroxicam].
Lang B; Hauk P; Meske S; Keller E; Peter HH
Z Rheumatol; 1991; 50(6):366-70. PubMed ID: 1796656
[TBL] [Abstract][Full Text] [Related]
54. A double-blind comparative study of piroxicam and ibuprofen in the treatment of rheumatoid arthritis.
McLaughlin GE
Semin Arthritis Rheum; 1985 Feb; 14(3 Suppl 1):11-3. PubMed ID: 3914701
[TBL] [Abstract][Full Text] [Related]
55. [Therapeutic action of Piroxicam administered rectally in rheumatic diseases. Controlled double-blind study].
Maccà F; Milani L; Dal Follo M; Corbetta L; Zeni G; Zuin R
Minerva Med; 1984 Apr; 75(14-15):811-9. PubMed ID: 6374502
[TBL] [Abstract][Full Text] [Related]
56. Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.
Santucci L; Fiorucci S; Chiucchiù S; Sicilia A; Bufalino L; Morelli A
Dig Dis Sci; 1992 Dec; 37(12):1825-32. PubMed ID: 1473431
[TBL] [Abstract][Full Text] [Related]
57. Piroxicam (CP 16171) in rheumatoid arthritis: a controlled clinical trial with novel assessment techniques.
Weintraub M; Jacox RF; Angevine CD; Atwater EC
J Rheumatol; 1977; 4(4):393-404. PubMed ID: 342691
[TBL] [Abstract][Full Text] [Related]
58. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
Vidal L; Kneer W; Baturone M; Sigmund R
Inflamm Res; 2001 Mar; 50 Suppl 1():S24-9. PubMed ID: 11339517
[TBL] [Abstract][Full Text] [Related]
59. A pharmacokinetic and endoscopic comparison of an oral and an experimental buccal piroxicam formulation.
Mueller BA; Rex DK; Figueroa N; Greene P; Brater DC
Pharmacotherapy; 1992; 12(2):93-7. PubMed ID: 1570233
[TBL] [Abstract][Full Text] [Related]
60. Naproxen and piroxicam. A comparative trial in rheumatoid arthritis.
Huskisson EC; Greenwood A
Eur J Rheumatol Inflamm; 1983; 6(3):242-6. PubMed ID: 6239778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
